GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » BactiQuant AS (OCSE:BACTIQ) » Definitions » EBIT

BactiQuant AS (OCSE:BACTIQ) EBIT : kr-13.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BactiQuant AS EBIT?

BactiQuant AS's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was kr-6.98 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was kr-13.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BactiQuant AS's annualized ROC % for the quarter that ended in Jun. 2024 was -121.23%. BactiQuant AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -275.27%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. BactiQuant AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -7.61%.

BactiQuant AS EBIT Historical Data

The historical data trend for BactiQuant AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BactiQuant AS EBIT Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial -0.39 -1.28 -12.61 -13.63 -11.58

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -6.64 -6.99 -5.56 -6.02 -6.98

Competitive Comparison of BactiQuant AS's EBIT

For the Pollution & Treatment Controls subindustry, BactiQuant AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BactiQuant AS's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, BactiQuant AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BactiQuant AS's EV-to-EBIT falls into.


BactiQuant AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-13.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS  (OCSE:BACTIQ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BactiQuant AS's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-14.244 * ( 1 - 0% )/( (11.54 + 11.96)/ 2 )
=-14.244/11.75
=-121.23 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=25.503 - 2.139 - ( 11.824 - max(0, 2.654 - 18.115+11.824))
=11.54

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=16.773 - 0.518 - ( 4.295 - max(0, 2.164 - 10.026+4.295))
=11.96

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

BactiQuant AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-13.952/( ( (1.193 + max(3.682, 0)) + (1.053 + max(4.209, 0)) )/ 2 )
=-13.952/( ( 4.875 + 5.262 )/ 2 )
=-13.952/5.0685
=-275.27 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.171 + 3.716 + 0.118) - (2.139 + 0 + 0.184)
=3.682

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.484 + 4.125 + 0.118) - (0.518 + 0 + 4.4408920985006E-16)
=4.209

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BactiQuant AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-12.995/170.789
=-7.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS EBIT Related Terms

Thank you for viewing the detailed overview of BactiQuant AS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BactiQuant AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » BactiQuant AS (OCSE:BACTIQ) » Definitions » EBIT
Comparable Companies
TSXV:HWY TSXV:TGOL TSXV:HCC TSX:FAR TSXV:AGH.H TSX:GEO TSXV:TNR TSXV:NMG.H TSXV:OC TSXV:NBR VLTO XBRU:UMI ZWS FSS TSE:6370 SZSE:300390 OSTO:MTRS SHSE:600388 SHSE:603279 ATMU
Traded in Other Exchanges
9JX:Germany
Address
Blokken 75, Birkeroed, DNK, DK-3460
Website
https://www.bactiquant.com
BactiQuant A/S focuses on delivering technology that ensures optimum usage and handling of water around the world. The technology supports four of the global goals which are access to clean water, sustainability in industry, responsible production and consumption, and the protection of marine life. It serves a wide range of customers and trades, ranging from salmon farmers to oil and gas companies and water distributors.

BactiQuant AS Headlines

No Headlines